BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22647601)

  • 1. Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
    Zhang MA; Rego D; Moshkova M; Kebir H; Chruscinski A; Nguyen H; Akkermann R; Stanczyk FZ; Prat A; Steinman L; Dunn SE
    Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9505-10. PubMed ID: 22647601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.
    Dunn SE; Ousman SS; Sobel RA; Zuniga L; Baranzini SE; Youssef S; Crowell A; Loh J; Oksenberg J; Steinman L
    J Exp Med; 2007 Feb; 204(2):321-30. PubMed ID: 17261635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonizing Peroxisome Proliferator-Activated Receptor α Activity Selectively Enhances Th1 Immunity in Male Mice.
    Zhang MA; Ahn JJ; Zhao FL; Selvanantham T; Mallevaey T; Stock N; Correa L; Clark R; Spaner D; Dunn SE
    J Immunol; 2015 Dec; 195(11):5189-202. PubMed ID: 26491197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
    Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
    Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
    Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
    PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response.
    Han XQ; Gong ZJ; Xu SQ; Li X; Wang LK; Wu SM; Wu JH; Yang HF
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):10-17. PubMed ID: 24496672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
    Comte D; Karampetsou MP; Kis-Toth K; Yoshida N; Bradley SJ; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2017 Apr; 69(4):808-813. PubMed ID: 27992687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis.
    Segawa S; Goto D; Iizuka A; Kaneko S; Yokosawa M; Kondo Y; Matsumoto I; Sumida T
    Clin Exp Immunol; 2016 Sep; 185(3):348-60. PubMed ID: 27083148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
    Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
    Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.
    Kim BJ; Jones HP
    Brain Behav Immun; 2010 Oct; 24(7):1126-36. PubMed ID: 20621581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal modulation of helper Th1 and Th17 cells by the β2-adrenergic receptor agonist drug terbutaline.
    Carvajal Gonczi CM; Tabatabaei Shafiei M; East A; Martire E; Maurice-Ventouris MHI; Darlington PJ
    FEBS J; 2017 Sep; 284(18):3018-3028. PubMed ID: 28710773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.
    Newcomb DC; Zhou W; Moore ML; Goleniewska K; Hershey GK; Kolls JK; Peebles RS
    J Immunol; 2009 May; 182(9):5317-21. PubMed ID: 19380778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells.
    Maeshima K; Yamaoka K; Kubo S; Nakano K; Iwata S; Saito K; Ohishi M; Miyahara H; Tanaka S; Ishii K; Yoshimatsu H; Tanaka Y
    Arthritis Rheum; 2012 Jun; 64(6):1790-8. PubMed ID: 22147632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.
    Klotz L; Burgdorf S; Dani I; Saijo K; Flossdorf J; Hucke S; Alferink J; Nowak N; Beyer M; Mayer G; Langhans B; Klockgether T; Waisman A; Eberl G; Schultze J; Famulok M; Kolanus W; Glass C; Kurts C; Knolle PA
    J Exp Med; 2009 Sep; 206(10):2079-89. PubMed ID: 19737866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I and type II cytokine production of CD4+ T-cells in immune response biased dairy cattle around calving.
    Paibomesai MA; Sharif S; Karrow N; Mallard BA
    Vet Immunol Immunopathol; 2018 May; 199():70-76. PubMed ID: 29678232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.
    Straus DS; Glass CK
    Trends Immunol; 2007 Dec; 28(12):551-8. PubMed ID: 17981503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of IL-17A-producing cells in celiac disease mucosa.
    Monteleone I; Sarra M; Del Vecchio Blanco G; Paoluzi OA; Franzè E; Fina D; Fabrizi A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2010 Feb; 184(4):2211-8. PubMed ID: 20061410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.